On Sunday, 12 January, the Regulation on Health Technology Assessment (HTA) will become applicable, bringing a significant improvement in ensuring that innovative and effective health technologies are available to patients across the EU.
The new rules create an EU framework for the assessment of health technologies, such as medicines and medical devices, by fostering collaboration and coordination between EU Member States. This will help national authorities to make more timely and informed decisions on the pricing and reimbursement of health technologies and streamline the procedure for health technology developers. This will contribute to faster and wider access to new and more effective innovative products for patients.

Go back
European Union
New EU Rules on Health Technology Assessment
The new rules open up a new era for patient access to innovation.
European Commission/AICEP
10th Jan 2025